Cholesterol-Lowering Supplements Industry Research Report 2025

Summary

According to APO Research, the global Cholesterol-Lowering Supplements market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Cholesterol-Lowering Supplements is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cholesterol-Lowering Supplements is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Cholesterol-Lowering Supplements is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Cholesterol-Lowering Supplements include Vitabiotics, TCI Co. Ltd., Streamline Pharma Pvt. Ltd., Step One Foods, Solgar, Pure Encapsulations LLC, ORGANIC INDIA Pvt. Ltd., Inlife Pharma Private Limite and Holland & Barrett, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cholesterol-Lowering Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholesterol-Lowering Supplements.

The report will help the Cholesterol-Lowering Supplements manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Cholesterol-Lowering Supplements market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cholesterol-Lowering Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Cholesterol-Lowering Supplements Segment by Company

Vitabiotics
TCI Co. Ltd.
Streamline Pharma Pvt. Ltd.
Step One Foods
Solgar
Pure Encapsulations LLC
ORGANIC INDIA Pvt. Ltd.
Inlife Pharma Private Limite
Holland & Barrett
Himalaya Wellness Company.
HERBAL CREATIONS
Croda International Plc
Cargill
Bioglan
ADM
Cholesterol-Lowering Supplements Segment by Type

Animal-Based
Plant-Based
Others
Cholesterol-Lowering Supplements Segment by Application

Online Sales
Offline Sales
Cholesterol-Lowering Supplements Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East Middle East & Africa
Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cholesterol-Lowering Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cholesterol-Lowering Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cholesterol-Lowering Supplements.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cholesterol-Lowering Supplements manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cholesterol-Lowering Supplements by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cholesterol-Lowering Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Cholesterol-Lowering Supplements Market Size (2020-2031)
2.2.2 Global Cholesterol-Lowering Supplements Sales (2020-2031)
2.2.3 Global Cholesterol-Lowering Supplements Market Average Price (2020-2031)
2.3 Cholesterol-Lowering Supplements by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Animal-Based
2.3.3 Plant-Based
2.3.4 Others
2.4 Cholesterol-Lowering Supplements by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Online Sales
2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
3.1 Global Cholesterol-Lowering Supplements Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Cholesterol-Lowering Supplements Sales (Tons) of Manufacturers (2020-2025)
3.3 Global Cholesterol-Lowering Supplements Revenue of Manufacturers (2020-2025)
3.4 Global Cholesterol-Lowering Supplements Average Price by Manufacturers (2020-2025)
3.5 Global Cholesterol-Lowering Supplements Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Cholesterol-Lowering Supplements, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Cholesterol-Lowering Supplements, Product Type & Application
3.8 Global Manufacturers of Cholesterol-Lowering Supplements, Established Date
3.9 Global Cholesterol-Lowering Supplements Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Vitabiotics
4.1.1 Vitabiotics Company Information
4.1.2 Vitabiotics Business Overview
4.1.3 Vitabiotics Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Vitabiotics Cholesterol-Lowering Supplements Product Portfolio
4.1.5 Vitabiotics Recent Developments
4.2 TCI Co. Ltd.
4.2.1 TCI Co. Ltd. Company Information
4.2.2 TCI Co. Ltd. Business Overview
4.2.3 TCI Co. Ltd. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.2.4 TCI Co. Ltd. Cholesterol-Lowering Supplements Product Portfolio
4.2.5 TCI Co. Ltd. Recent Developments
4.3 Streamline Pharma Pvt. Ltd.
4.3.1 Streamline Pharma Pvt. Ltd. Company Information
4.3.2 Streamline Pharma Pvt. Ltd. Business Overview
4.3.3 Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Streamline Pharma Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio
4.3.5 Streamline Pharma Pvt. Ltd. Recent Developments
4.4 Step One Foods
4.4.1 Step One Foods Company Information
4.4.2 Step One Foods Business Overview
4.4.3 Step One Foods Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Step One Foods Cholesterol-Lowering Supplements Product Portfolio
4.4.5 Step One Foods Recent Developments
4.5 Solgar
4.5.1 Solgar Company Information
4.5.2 Solgar Business Overview
4.5.3 Solgar Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Solgar Cholesterol-Lowering Supplements Product Portfolio
4.5.5 Solgar Recent Developments
4.6 Pure Encapsulations LLC
4.6.1 Pure Encapsulations LLC Company Information
4.6.2 Pure Encapsulations LLC Business Overview
4.6.3 Pure Encapsulations LLC Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Pure Encapsulations LLC Cholesterol-Lowering Supplements Product Portfolio
4.6.5 Pure Encapsulations LLC Recent Developments
4.7 ORGANIC INDIA Pvt. Ltd.
4.7.1 ORGANIC INDIA Pvt. Ltd. Company Information
4.7.2 ORGANIC INDIA Pvt. Ltd. Business Overview
4.7.3 ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.7.4 ORGANIC INDIA Pvt. Ltd. Cholesterol-Lowering Supplements Product Portfolio
4.7.5 ORGANIC INDIA Pvt. Ltd. Recent Developments
4.8 Inlife Pharma Private Limite
4.8.1 Inlife Pharma Private Limite Company Information
4.8.2 Inlife Pharma Private Limite Business Overview
4.8.3 Inlife Pharma Private Limite Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Inlife Pharma Private Limite Cholesterol-Lowering Supplements Product Portfolio
4.8.5 Inlife Pharma Private Limite Recent Developments
4.9 Holland & Barrett
4.9.1 Holland & Barrett Company Information
4.9.2 Holland & Barrett Business Overview
4.9.3 Holland & Barrett Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Holland & Barrett Cholesterol-Lowering Supplements Product Portfolio
4.9.5 Holland & Barrett Recent Developments
4.10 Himalaya Wellness Company.
4.10.1 Himalaya Wellness Company. Company Information
4.10.2 Himalaya Wellness Company. Business Overview
4.10.3 Himalaya Wellness Company. Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Himalaya Wellness Company. Cholesterol-Lowering Supplements Product Portfolio
4.10.5 Himalaya Wellness Company. Recent Developments
4.11 HERBAL CREATIONS
4.11.1 HERBAL CREATIONS Company Information
4.11.2 HERBAL CREATIONS Business Overview
4.11.3 HERBAL CREATIONS Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.11.4 HERBAL CREATIONS Cholesterol-Lowering Supplements Product Portfolio
4.11.5 HERBAL CREATIONS Recent Developments
4.12 Croda International Plc
4.12.1 Croda International Plc Company Information
4.12.2 Croda International Plc Business Overview
4.12.3 Croda International Plc Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Croda International Plc Cholesterol-Lowering Supplements Product Portfolio
4.12.5 Croda International Plc Recent Developments
4.13 Cargill
4.13.1 Cargill Company Information
4.13.2 Cargill Business Overview
4.13.3 Cargill Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Cargill Cholesterol-Lowering Supplements Product Portfolio
4.13.5 Cargill Recent Developments
4.14 Bioglan
4.14.1 Bioglan Company Information
4.14.2 Bioglan Business Overview
4.14.3 Bioglan Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Bioglan Cholesterol-Lowering Supplements Product Portfolio
4.14.5 Bioglan Recent Developments
4.15 ADM
4.15.1 ADM Company Information
4.15.2 ADM Business Overview
4.15.3 ADM Cholesterol-Lowering Supplements Sales, Revenue and Gross Margin (2020-2025)
4.15.4 ADM Cholesterol-Lowering Supplements Product Portfolio
4.15.5 ADM Recent Developments
5 Global Cholesterol-Lowering Supplements Market Scenario by Region
5.1 Global Cholesterol-Lowering Supplements Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Cholesterol-Lowering Supplements Sales by Region: 2020-2031
5.2.1 Global Cholesterol-Lowering Supplements Sales by Region: 2020-2025
5.2.2 Global Cholesterol-Lowering Supplements Sales by Region: 2026-2031
5.3 Global Cholesterol-Lowering Supplements Revenue by Region: 2020-2031
5.3.1 Global Cholesterol-Lowering Supplements Revenue by Region: 2020-2025
5.3.2 Global Cholesterol-Lowering Supplements Revenue by Region: 2026-2031
5.4 North America Cholesterol-Lowering Supplements Market Facts & Figures by Country
5.4.1 North America Cholesterol-Lowering Supplements Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Cholesterol-Lowering Supplements Sales by Country (2020-2031)
5.4.3 North America Cholesterol-Lowering Supplements Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Cholesterol-Lowering Supplements Market Facts & Figures by Country
5.5.1 Europe Cholesterol-Lowering Supplements Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Cholesterol-Lowering Supplements Sales by Country (2020-2031)
5.5.3 Europe Cholesterol-Lowering Supplements Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Cholesterol-Lowering Supplements Market Facts & Figures by Country
5.6.1 Asia Pacific Cholesterol-Lowering Supplements Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Cholesterol-Lowering Supplements Sales by Country (2020-2031)
5.6.3 Asia Pacific Cholesterol-Lowering Supplements Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Cholesterol-Lowering Supplements Market Facts & Figures by Country
5.7.1 South America Cholesterol-Lowering Supplements Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Cholesterol-Lowering Supplements Sales by Country (2020-2031)
5.7.3 South America Cholesterol-Lowering Supplements Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Cholesterol-Lowering Supplements Market Facts & Figures by Country
5.8.1 Middle East and Africa Cholesterol-Lowering Supplements Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Cholesterol-Lowering Supplements Sales by Country (2020-2031)
5.8.3 Middle East and Africa Cholesterol-Lowering Supplements Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Cholesterol-Lowering Supplements Sales by Type (2020-2031)
6.1.1 Global Cholesterol-Lowering Supplements Sales by Type (2020-2031) & (Tons)
6.1.2 Global Cholesterol-Lowering Supplements Sales Market Share by Type (2020-2031)
6.2 Global Cholesterol-Lowering Supplements Revenue by Type (2020-2031)
6.2.1 Global Cholesterol-Lowering Supplements Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Cholesterol-Lowering Supplements Revenue Market Share by Type (2020-2031)
6.3 Global Cholesterol-Lowering Supplements Price by Type (2020-2031)
7 Segment by Application
7.1 Global Cholesterol-Lowering Supplements Sales by Application (2020-2031)
7.1.1 Global Cholesterol-Lowering Supplements Sales by Application (2020-2031) & (Tons)
7.1.2 Global Cholesterol-Lowering Supplements Sales Market Share by Application (2020-2031)
7.2 Global Cholesterol-Lowering Supplements Revenue by Application (2020-2031)
7.2.1 Global Cholesterol-Lowering Supplements Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Cholesterol-Lowering Supplements Revenue Market Share by Application (2020-2031)
7.3 Global Cholesterol-Lowering Supplements Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Cholesterol-Lowering Supplements Value Chain Analysis
8.1.1 Cholesterol-Lowering Supplements Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Cholesterol-Lowering Supplements Production Mode & Process
8.2 Cholesterol-Lowering Supplements Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Cholesterol-Lowering Supplements Distributors
8.2.3 Cholesterol-Lowering Supplements Customers
9 Global Cholesterol-Lowering Supplements Analyzing Market Dynamics
9.1 Cholesterol-Lowering Supplements Industry Trends
9.2 Cholesterol-Lowering Supplements Industry Drivers
9.3 Cholesterol-Lowering Supplements Industry Opportunities and Challenges
9.4 Cholesterol-Lowering Supplements Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings